XML 121 R107.htm IDEA: XBRL DOCUMENT v3.22.1
Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting Information, Profit (Loss):      
Total segment revenues $ 1,086,812 $ 943,365 $ 963,010
Cost of sales 466,166 395,893 410,787
Gross profit 620,646 547,472 552,223
Advertising and marketing 157,343 140,589 147,194
Contribution margin 463,303 406,883 405,029
Other operating expenses 133,384 109,481 113,874
Operating income 329,919 297,402 291,155
North American OTC Healthcare      
Segment Reporting Information, Profit (Loss):      
Total segment revenues 967,881 849,319 859,368
Cost of sales 419,162 359,100 372,133
Gross profit 548,719 490,219 487,235
Advertising and marketing 138,714 122,857 127,972
Contribution margin 410,005 367,362 359,263
North American OTC Healthcare | Intersegment Eliminations      
Segment Reporting Information, Profit (Loss):      
Total segment revenues 3,000 3,200 3,500
International OTC Healthcare      
Segment Reporting Information, Profit (Loss):      
Total segment revenues 118,931 94,046 103,642
Cost of sales 47,004 36,793 38,654
Gross profit 71,927 57,253 64,988
Advertising and marketing 18,629 17,732 19,222
Contribution margin $ 53,298 $ 39,521 $ 45,766